Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Nedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity.

Endocrinology | 2015

Neural precursor cell expressed developmentally down-regulated protein 4 (Nedd4) is the prototypical protein in the Nedd4 ubiquitin ligase (E3) family, which governs ubiquitin-dependent endocytosis and/or degradation of plasma membrane proteins. Loss of Nedd4 results in embryonic or neonatal lethality in mice and reduced insulin/IGF-1 signaling in embryonic fibroblasts. To delineate the roles of Nedd4 in vivo, we examined the phenotypes of heterozygous knockout mice using a high-fat diet-induced obesity (HFDIO) model. We observed that Nedd4+/- mice are moderately insulin resistant but paradoxically protected against HFDIO. After high-fat diet feeding, Nedd4+/- mice showed less body weight gain, less fat mass, and smaller adipocytes vs the wild type. Despite ameliorated HFDIO, Nedd4+/- mice did not manifest improvement in glucose tolerance vs the wild type in both genders. Nedd4+/- male, but not female, mice displayed significantly lower fasting blood glucose levels and serum insulin levels. Under obesogenic conditions, Nedd4+/- mice displayed elevated stimulated lipolytic activity, primarily through a β2-adrenergic receptor. Combined, these data support novel complex roles for Nedd4 in metabolic regulation involving altered insulin and β-adrenergic signaling pathways.

Pubmed ID: 25607895 RIS Download

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL085848
  • Agency: NIA NIH HHS, United States
    Id: R01 AG031893
  • Agency: NIA NIH HHS, United States
    Id: R21 AG041934
  • Agency: NINDS NIH HHS, United States
    Id: R21 NS083908
  • Agency: NICHD NIH HHS, United States
    Id: R21 HD059292
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL107500
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK085465
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL-085848

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


IGF-I Receptor beta Antibody (antibody)

RRID:AB_2122378

This polyclonal targets Igf1r

View all literature mentions

Insulin Receptor β (4B8) Rabbit mAb (antibody)

RRID:AB_2280448

This recombinant monoclonal targets Insulin Receptor beta

View all literature mentions

Monoclonal Anti-Actin antibody produced in mouse (antibody)

RRID:AB_262137

This monoclonal targets Actin antibody produced in mouse

View all literature mentions

Anti-Nedd4, WW2 domain (antibody)

RRID:AB_310351

This polyclonal targets Nedd4, WW2 domain

View all literature mentions

Phospho-Akt (Ser473) Antibody (antibody)

RRID:AB_329825

This polyclonal targets Phospho-Akt (Ser473)

View all literature mentions

Akt Antibody (antibody)

RRID:AB_329827

This polyclonal targets Akt

View all literature mentions

Phospho-IGF-I Receptor beta (Tyr1135/1136)/Insulin Receptor beta (Tyr1150/1151) (19H7) Rabbit mAb (antibody)

RRID:AB_331253

This monoclonal targets Phospho-IGF-I Receptor beta (Tyr1135/1136)/Insulin Receptor beta (Tyr1150/1151) (19H7) Rabbit mAb

View all literature mentions

GAPDH (6C5) (antibody)

RRID:AB_627679

This monoclonal targets GAPDH (6C5)

View all literature mentions

beta2-AR (H-20) (antibody)

RRID:AB_630926

This polyclonal targets ADRB2

View all literature mentions